TY - JOUR
T1 - Blood Compatibility of Hydrophilic Polyphosphoesters
AU - Pelosi, Chiara
AU - Constantinescu, Iren
AU - Son, Helena H.
AU - Tinè, Maria Rosaria
AU - Kizhakkedathu, Jayachandran N.
AU - Wurm, Frederik R.
N1 - Funding Information:
The project was funded by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Council of Canada (NSERC). The Centre of Blood Research infrastructure facility was funded by the Canada Foundation for Innovation (CFI) and the British Columbia Knowledge Development Fund (BCKDF). F.R.W. thanks the Deutsche Forschungsgemeinschaft (DFG) for funding (WU750/6–2).
Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.
PY - 2022/3/21
Y1 - 2022/3/21
N2 - Polyphosphoesters (PPEs) are a class of versatile degradable polymers. Despite the high potential of this class of polymers in biomedical applications, little is known about their blood interaction and compatibility. We evaluated the hemocompatibility of water-soluble PPEs (with different hydrophilicities and molar masses) and PPE-coated model nanocarriers. Overall, we identified high hemocompatibility of PPEs, comparable to poly(ethylene glycol) (PEG), currently used for many applications in nanomedicine. Hydrophilic PPEs caused no significant changes in blood coagulation, negligible platelet activation, the absence of red blood cells lysis, or aggregation. However, when a more hydrophobic copolymer was studied, some changes in the whole blood clot strength at the highest concentration were detected, but only concentrations above that are typically used for biomedical applications. Also, the PPE-coated model nanocarriers showed high hemocompatibility. These results contribute to defining hydrophilic PPEs as a promising platform for degradable and biocompatible materials in the biomedical field.
AB - Polyphosphoesters (PPEs) are a class of versatile degradable polymers. Despite the high potential of this class of polymers in biomedical applications, little is known about their blood interaction and compatibility. We evaluated the hemocompatibility of water-soluble PPEs (with different hydrophilicities and molar masses) and PPE-coated model nanocarriers. Overall, we identified high hemocompatibility of PPEs, comparable to poly(ethylene glycol) (PEG), currently used for many applications in nanomedicine. Hydrophilic PPEs caused no significant changes in blood coagulation, negligible platelet activation, the absence of red blood cells lysis, or aggregation. However, when a more hydrophobic copolymer was studied, some changes in the whole blood clot strength at the highest concentration were detected, but only concentrations above that are typically used for biomedical applications. Also, the PPE-coated model nanocarriers showed high hemocompatibility. These results contribute to defining hydrophilic PPEs as a promising platform for degradable and biocompatible materials in the biomedical field.
KW - biodegradable polymers
KW - blood coagulation
KW - hemocompatibility
KW - platelet activation
KW - poly(ethylene glycol)
KW - polyphosphoesters
KW - RBC interaction
KW - UT-Hybrid-D
UR - http://www.scopus.com/inward/record.url?scp=85125620904&partnerID=8YFLogxK
U2 - 10.1021/acsabm.1c01210
DO - 10.1021/acsabm.1c01210
M3 - Article
C2 - 35201742
AN - SCOPUS:85125620904
SN - 2576-6422
VL - 5
SP - 1151
EP - 1158
JO - ACS Applied Bio Materials
JF - ACS Applied Bio Materials
IS - 3
ER -